Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunal Malik

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Investigative Dermatology|April 14, 2022
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier SignaturesMadeline Kim, Daniela Mikhaylov, Stephanie M Rangel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trialTali Czarnowicki, Anders B Dohlman, Kunal Malik, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 15, 2019
Philadelphia glaucoma detection and treatment project: ocular outcomes and adherence to follow-up at a single health centreJennifer O Adeghate, Lisa A Hark, Helayna Brown, et al.
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|November 6, 2019
Uveal metastasis in 1111 patients: Interval to metastasis and overall survival based on timing of primary cancer diagnosisR Joel Welch, Kunal Malik, Eileen L Mayro, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2018
Serum from Asian patients with atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>22 activation, which is highly correlated with nonlesional skin measuresHuei-Chi Wen, Tali Czarnowicki, Shinji Noda, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
Middle East African Journal of Ophthalmology|August 21, 2018
Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor OriginCarol L Shields, R Joel Welch, Kunal Malik, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Investigative Dermatology|April 14, 2022
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier SignaturesMadeline Kim, Daniela Mikhaylov, Stephanie M Rangel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trialTali Czarnowicki, Anders B Dohlman, Kunal Malik, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 15, 2019
Philadelphia glaucoma detection and treatment project: ocular outcomes and adherence to follow-up at a single health centreJennifer O Adeghate, Lisa A Hark, Helayna Brown, et al.
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|November 6, 2019
Uveal metastasis in 1111 patients: Interval to metastasis and overall survival based on timing of primary cancer diagnosisR Joel Welch, Kunal Malik, Eileen L Mayro, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2018
Serum from Asian patients with atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>22 activation, which is highly correlated with nonlesional skin measuresHuei-Chi Wen, Tali Czarnowicki, Shinji Noda, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
Middle East African Journal of Ophthalmology|August 21, 2018
Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor OriginCarol L Shields, R Joel Welch, Kunal Malik, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Pageof 4